Evidence / Mieszkowski et al. · 2024
Ubiquinone and blood markers after exercise
Selected research. Study type, product relevance and limitations are shown separately.
Editorial study summary
- Study type
- Double-blind randomized controlled human trial.
- Product relevance
- Ingredient evidence for oxidized CoQ10, or ubiquinone, as identified in the paper title.
- Sample or population
- 28 healthy men.
- Studied dose
- Not reported in the abstract.
- Duration
- 21 days.
- Finding
- Serum CoQ10 rose with supplementation. Several exercise-related blood markers changed, and post-exercise 25(OH)D3 rose only in the placebo group.
- Limitations
- The trial measured biochemical responses to exercise. It did not establish a performance or recovery benefit.
- Study quality
- Controlled trial with an exercise challenge and serial blood sampling. Editorial review was limited to the abstract. No formal risk-of-bias rating was assigned.
- Funding and disclosures
- Funding and conflicts were not verified from the abstract.
The studies discussed here examine ingredients or other formulations. They do not establish results for this DR.MORGAN finished product.